GGrantIndex
Sort

48,018 grants matching immunotherapy

Project 3: Spherical Nucleic Acids as Immunotherapeutic Agents for Prostate Cancer

$601,282
Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2019 · CA

Inflammation and Cancer

$601,256
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas

$601,230
Elias Sayour · University Of Florida · R37 · FY2024 · CA

INHIBITING MDSC BIOGENESIS TO AUGMENT IMMUNOTHERAPY EFFICACY IN TRIPLE-NEGATIVE BREAST CANCER

$601,167
Health Research, Inc. · · FY2021 · Defense Health Agency

Validation of a novel 3D culture platform for TNBC treatment selection

$601,157
Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2023 · CA

Metabolism of cancer chemotherapeutics by the human gut microbiome

$601,043
Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2025 · CA

UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center

$600,941
Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2025 · CA

Dual action immunostimulatory nanoparticles for treatment of aggressive cancers

$600,913
Efstathios Karathanasis · Case Western Reserve University · R01 · FY2023 · CA

Exploiting the Mechanobiology of PD-1 for Cancer Immunotherapy

$600,878
Cheng Zhu · Georgia Institute Of Technology · U01 · FY2024 · CA

IL-2R-dependent mechanisms in regulation of Treg homeostasis and autoimmunity

$600,832
Thomas R Malek · University Of Miami School Of Medicine · R01 · FY2025 · AI

TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION

$600,798
Alexander V Kabanov · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA

Development of a 3D multi-modal perfusion-thermal electrode system

$600,529
Xiaoming Yang · University Of Washington · R01 · FY2019 · EB

Immune manipulation to generate tumor immunity and regulate GVHD after allogeneic HCT

$600,510
Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2022 · CA

Targeting Aldehyde Dehydrogenase for Cancer Prevention

$600,507
Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA

Functional roles of human pulmonary DC's in the lung draining lymph nodes

$600,371
Claudia V Jakubzick · National Jewish Health · R01 · FY2017 · HL

Decoupling acute toxicities and antitumor efficacy in adoptive cell therapy

$600,313
Yong Lu · Methodist Hospital Research Institute · R01 · FY2024 · CA

Linking insertional mutagenesis and cell function to improve CAR T cell therapy

$600,298
Frederic D Bushman · University Of Pennsylvania · R01 · FY2022 · CA

Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung

$600,295
Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · CA

Influences of the Microenvironment on Cancer Stem Cells

$600,277
Hong Wu · University Of California Los Angeles · U01 · FY2012 · CA

PD-1/PD-L1 modulation in cancer therapy

$600,140
Drew M. Pardoll · Johns Hopkins University · R01 · FY2023 · CA

PD-1/PD-L1 modulation in cancer therapy

$600,140
Drew M. Pardoll · Johns Hopkins University · R01 · FY2025 · CA

PD-1/PD-L1 modulation in cancer therapy

$600,139
Drew M. Pardoll · Johns Hopkins University · R01 · FY2021 · CA

Clinical Cancer Cytogenetics

$600,109
Diane C Arthur · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Immunotherapy Strategies for Uveal Melanoma

$600,058
Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy

$600,058
Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA